114 related articles for article (PubMed ID: 2862948)
1. Effects of a selective beta 2-blocker (ICI 118,551) on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
Jenkins SA; Baxter JN; Johnston JN; Devitt P; Shields R
Br J Surg; 1985 Aug; 72(8):653-6. PubMed ID: 2862948
[TBL] [Abstract][Full Text] [Related]
2. Effects of propranolol on hepatic haemodynamics in the cirrhotic and non-cirrhotic rat.
Jenkins SA; Baxter JN; Johnson JN; Devitt P; Shields R
Br J Surg; 1985 May; 72(5):354-8. PubMed ID: 3995241
[TBL] [Abstract][Full Text] [Related]
3. The effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the cirrhotic rat.
Jenkins SA; Baxter JN; Corbett WA; Shields R
Br J Surg; 1985 Nov; 72(11):864-7. PubMed ID: 2866012
[TBL] [Abstract][Full Text] [Related]
4. Effect of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model.
Kroeger RJ; Groszmann RJ
Gastroenterology; 1985 Apr; 88(4):896-900. PubMed ID: 2857673
[TBL] [Abstract][Full Text] [Related]
5. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
[TBL] [Abstract][Full Text] [Related]
6. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
Reiberger T; Payer BA; Schwabl P; Hayden H; Horvatits T; Jäger B; Hummel T; Mitterhauser M; Trauner M; Fuhrmann V; Angermayr B; Peck-Radosavljevic M;
Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
[TBL] [Abstract][Full Text] [Related]
7. Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.
Cavasin MA; Semus H; Pitts K; Peng Y; Sandoval J; Chapo J; Plato CF
Can J Physiol Pharmacol; 2010 Jun; 88(6):636-43. PubMed ID: 20628429
[TBL] [Abstract][Full Text] [Related]
8. Beta adrenergic stimulation and blockade in cirrhosis: effects on azygos vein blood flow and portal hemodynamics.
Weinshel EH; Altszuler HM; Raicht RF; Sedlis SP
Am J Med Sci; 1994 Jun; 307(6):396-400. PubMed ID: 7911005
[TBL] [Abstract][Full Text] [Related]
9. Reduced splanchnic vasoconstriction to angiotensin II in conscious rats with biliary cirrhosis.
Braillon A; Cailmail S; Gaudin C; Lebrec D
J Hepatol; 1993 Jan; 17(1):86-90. PubMed ID: 8445224
[TBL] [Abstract][Full Text] [Related]
10. Mixed endothelin receptor antagonist, SB209670, decreases portal pressure in biliary cirrhotic rats in vivo by reducing portal venous system resistance.
Kojima H; Yamao J; Tsujimoto T; Uemura M; Takaya A; Fukui H
J Hepatol; 2000 Jan; 32(1):43-50. PubMed ID: 10673066
[TBL] [Abstract][Full Text] [Related]
11. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
[TBL] [Abstract][Full Text] [Related]
12. Propranolol decreases portal pressure without changing portocollateral resistance in cirrhotic rats.
Pizcueta MP; de Lacy AM; Kravetz D; Bosch J; Rodés J
Hepatology; 1989 Dec; 10(6):953-7. PubMed ID: 2583690
[TBL] [Abstract][Full Text] [Related]
13. Role of hepatic artery in haemodynamics in normal and cirrhotic livers in rats.
Shibayama Y; Nakata K
J Gastroenterol Hepatol; 1991; 6(6):591-4. PubMed ID: 1782375
[TBL] [Abstract][Full Text] [Related]
14. Reductions in portal pressure by selective beta 2-adrenoceptor blockade in patients with cirrhosis and portal hypertension.
Bihari D; Westaby D; Gimson A; Crossley I; Harry J; Williams R
Br J Clin Pharmacol; 1984 Jun; 17(6):753-7. PubMed ID: 6146330
[TBL] [Abstract][Full Text] [Related]
15. Effects of carbon dioxide pneumoperitoneum on hemodynamics in cirrhotic rats.
Tsuboi S; Kitano S; Yoshida T; Bandoh T; Ninomiya K; Baatar D
Surg Endosc; 2002 Aug; 16(8):1220-5. PubMed ID: 11984669
[TBL] [Abstract][Full Text] [Related]
16. Portal hypertension and liver cirrhosis in rats: effect of the β3-adrenoceptor agonist SR58611A.
Vasina V; Giannone F; Domenicali M; Latorre R; Berzigotti A; Caraceni P; Zoli M; De Ponti F; Bernardi M
Br J Pharmacol; 2012 Nov; 167(5):1137-47. PubMed ID: 22708587
[TBL] [Abstract][Full Text] [Related]
17. Comparative portal hypotensive effects as propranolol of vitamin D₃ treatment by decreasing intrahepatic resistance in cirrhotic rats.
Lee PC; Yang YY; Lee WP; Lee KC; Hsieh YC; Lee TY; Lin HC
J Gastroenterol Hepatol; 2015 Mar; 30(3):628-37. PubMed ID: 25187428
[TBL] [Abstract][Full Text] [Related]
18. Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.
Tripathi DM; Erice E; Lafoz E; García-Calderó H; Sarin SK; Bosch J; Gracia-Sancho J; García-Pagán JC
Am J Physiol Gastrointest Liver Physiol; 2015 Sep; 309(5):G301-9. PubMed ID: 26138461
[TBL] [Abstract][Full Text] [Related]
19. Effects of fasudil on the portal and systemic hemodynamics of patients with cirrhosis.
Fukuda T; Narahara Y; Kanazawa H; Matsushita Y; Kidokoro H; Itokawa N; Kondo C; Atsukawa M; Nakatsuka K; Sakamoto C
J Gastroenterol Hepatol; 2014 Feb; 29(2):325-9. PubMed ID: 24033356
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of terbutaline, a beta 2-adrenoceptor agonist, in conscious rats with secondary biliary cirrhosis.
Poo JL; Braillon A; Hadengue A; Gaudin C; Lebrec D
Hepatology; 1992 Mar; 15(3):459-63. PubMed ID: 1347507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
